Therapeutic Asset Ratings

423 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Dat-1604 Cancer	Danatlas Pharmaceuticals Co., Ltd	P1	NR (0)
fs-207 Cancer	Foresight Therapeutics (Hefei) Co., Ltd.	P1	NR (0)
hs-10529 Cancer	Jiangsu Hansoh Pharmaceutical Co., Ltd.	P1	NR (0)
Icp-B794 Cancer	Beijing InnoCare Pharma Tech Co., Ltd.	P1	NR (0)
in10028 Cancer	InxMed (Shanghai) Co., Ltd.	P1	NR (0)
kh801 Cancer	Beijing Kanghong Biopharmaceutical Co., Ltd.	P1	NR (0)
kh815 for Cancer	Chengdu Kanghong Biotech Co., Ltd.	P1	NR (0)
km501 Cancer	Xuanzhu Biopharmaceutical Co., Ltd.	P1	NR (0)
qlm2011 Cancer	Qilu Pharmaceutical (Hainan) Co., Ltd.	P1	NR (0)
R-Star001 Cancer	changjianhua	P1	NR (0)
sys6051 Cancer	CSPC Megalith Biopharmaceutical Co.,Ltd.	P1	NR (0)
Allogeneic Wtx-212C Cancer	Zhejiang Provincial People's Hospital	Early P1	NR (0)
yy2201 Cancer	Jiangsu YaYao Biotechnology Co., Ltd.	Early P1	NR (0)
Asn-3186 Cancer	Jiangsu Yahong Meditech Co., Ltd aka Asieris	P1/2	NR (0)
Cho-A04 Cancer	Cho Pharma Inc.	P1/2	NR (0)
lcb02a Cancer	LigaChem Biosciences, Inc.	P1/2	NR (0)
qls5133 Cancer	Qilu Pharmaceutical Co., Ltd.	P1/2	NR (0)
Shr-9803 Cancer	Jiangsu HengRui Medicine Co., Ltd.	P1/2	NR (0)
skb118 Cancer	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	P1/2	NR (0)
skb565 Cancer	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.	P1/2	NR (0)
sys6006 Cancer	CSPC Megalith Biopharmaceutical Co.,Ltd.	P1/2	NR (0)
xnw34017 Cancer	Evopoint Biosciences Inc.	P1/2	NR (0)
yb1-x7 Cancer	Shanghai Salvectors Biotechnology LTD.	N/A	NR (0)

Showing 401 to 423 of 423 assets

PreviousPage 17 of 17Next